Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000122200 | SCV000153104 | likely benign | not specified | 2014-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080188 | SCV000284662 | benign | Tuberous sclerosis 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000398057 | SCV000478245 | likely benign | Isolated focal cortical dysplasia type II | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001080188 | SCV000478246 | likely benign | Tuberous sclerosis 1 | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000122200 | SCV000527394 | benign | not specified | 2018-01-31 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000572872 | SCV000675346 | likely benign | Hereditary cancer-predisposing syndrome | 2018-04-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001080188 | SCV002040478 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000572872 | SCV002530870 | likely benign | Hereditary cancer-predisposing syndrome | 2020-12-09 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002490461 | SCV002799201 | likely benign | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV002490461 | SCV003920597 | likely benign | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2022-07-12 | criteria provided, single submitter | clinical testing | TSC1 NM_000368.4 exon 10 p.Ser334Leu (c.1001C>T): This variant has been reported in the literature in at least 1 individual with nonalcoholic fatty liver disease (Pelusi 2019 PMID:30842500). This variant is present in the Genome Aggregation Database (Highest reported MAF 0.01% (13/67998) (https://gnomad.broadinstitute.org/variant/9-132911481-G-A?dataset=gnomad_r3)). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign (Variation ID:41686). This variant amino acid Leucine (Leu) is present in multiple species including mammals and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. |
Ce |
RCV000034598 | SCV004156654 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | TSC1: BP4, BS1 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000034598 | SCV004221379 | benign | not provided | 2019-10-18 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000054847 | SCV004840501 | benign | Tuberous sclerosis syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000034598 | SCV005225986 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Biesecker Lab/Clinical Genomics Section, |
RCV000034598 | SCV000043518 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |
Tuberous sclerosis database |
RCV000054847 | SCV000065752 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
ITMI | RCV000122200 | SCV000086419 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Diagnostic Laboratory, |
RCV000034598 | SCV001741806 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000122200 | SCV001966265 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003944882 | SCV004775245 | likely benign | TSC1-related disorder | 2019-03-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |